Govt invites proposals for medical device manufacturing; offers up to Rs 10 crore subsidy

Business & Finance
29 Jun 2026 • 6:56 PM MYT
Tribune
Tribune

Breaking news, top headlines, in-depth analysis, & exclusive stories

Image from: Govt invites proposals for medical device manufacturing; offers up to Rs 10 crore subsidy

New Delhi [India], June 29 (ANI): In a boost to India’s medical device manufacturing industry, the Government has invited applications from eligible entities under the Scheme for Strengthening of Medical Device Industry (SMDI), as per a statement by the Ministry of Chemicals and Fertilisers.

According to the release, applications are invited under two key sub-schemes to promote domestic manufacturing, reduce import dependence, support innovation and boost value chains in India’s medical devices sector. Furthermore, the selected candidates will be eligible for a significant financial benefit of up to Rs 10 crore.

The two sub-schemes are namely– Marginal Investment Scheme for Reducing Import Dependence and Medical Device Clinical Studies Support Scheme (MDCSS).

As per the release, under the Marginal Investment Scheme, selected applicants will be eligible for a one-time capital subsidy of up to Rs 10 crore on a reimbursement basis for manufacturing key components, raw materials, finished devices or accessories aimed at reducing import dependence.

“Selected applicants would be incentivised through a one-time capital subsidy of up to Rs 10 crore on a reimbursement basis for manufacturing key components/ raw material/ finished devices/ accessories to reduce import dependence under the Marginal Investment Scheme," the release said.

Apart from this, under the MDCSS, the government will provide financial assistance of up to Rs 5 crore to the applicants for conducting clinical investigations, clinical performance evaluations, post-market follow-up studies and animal studies, also on a reimbursement basis.

“The department will provide financial support of up to ₹5 crore under the MDCSS Scheme for conducting clinical investigation/clinical performance evaluation/Post Market Follow-up Study/animal studies to the eligible applicants on a reimbursement basis," the release said.

Eligible applicants are required to submit proposals online through the official portal http://smdi.lsssdc.in on or before July 23, 2026 (6:00 PM). Detailed guidelines, eligibility criteria and application procedures are available on the Department of Pharmaceuticals website at https://pharma-dept.gov.in/schemes. (ANI)

(This content is sourced from a syndicated feed and is published as received. The Tribune assumes no responsibility or liability for its accuracy, completeness, or content.)

Newswav Malaysia Best News App

Newswav is an online content aggregator and obtains its content from different online sources. The content in the app do not belong to Newswav nor do they reflect the opinions of Newswav and its staff. Your use of this app indicates your understanding and acceptance of this information.

Newswav Sdn. Bhd. (201701008480 (1222645-M)) 2026 All Rights Reserved